«Vaccinia

Below is an extended Vaccinia patents listing. Click here to return to the Vaccinia main in depth entry.

Patents :
US Patent No.	Title
7425536	Feline hepatocyte growth factor
7427395	Chemotherapeutic agent-incorporated pharmaceutical preparation
7427396	AAV vectors for gene delivery to the lung
7427399	Antibodies and related molecules that bind to 161P2F10B proteins
7427468	Anti-TSG101 antibodies and their uses for treatment of viral infections
7427469	Method of treating cytomegalovirus with DC-SIGN blockers
7427476	PITX2 polynucleotide, polypeptide and methods of use therefor
7427478	Beta-secretase enzyme compositions and methods
7427479	Methods and kits for identifying target nucleotides in mixed populations
7427488	Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same
7427489	Screening assay to identify modulators of the sleep/wake cycle
7426441	Methods for determining renal toxins
7425624	Sulfotransferase 1A3 sequence variants
7425622	Antibodies against C3a receptor
7425538	HAUSP-p53 interaction and uses thereof
7425553	Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
7425606	Method for screening peptides for use in immunotherapy
7425607	Compositions comprising a lung tumor antigen
7425611	Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use
7425615	Protein specific for cardiac and skeletal muscle
7425617	Antibodies to the cell cycle regulatory protein p16
7425618	Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
7425619	Fc.gamma.RIIB specific antibodies and methods of use thereof
7425620	Fc.gamma.RIIB-specific antibodies and methods of use thereof
7427492	Polynucleotides encoding human tumor necrosis factor receptor-like2
7427494	Nucleic acid encoding cytokine receptor zcytor17
7429473	Diacylglycerol acyltransferase genes, proteins, and uses thereof
7429480	Promoter sequences from WSSV immediate early genes and their uses in recombinant DNA techniques
7429481	Targeting viruses using a modified sindbis glycoprotein
7429482	Screening tools for discovery of novel anabolic agents
7429639	SSX-2 peptides presented by HLA class II molecules
7429643	POSH nucleic acids, polypeptides and related methods
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7429648	IREN protein, its preparation and use
7429653	Stabilized soluble glycoprotein trimers
7429690	Transgenic bovines having reduced prion protein production
7429461	Genetic products differentially expressed in tumors and use thereof
7429450	HIP1 cancer markers
7429448	Therapeutic use of the SMR1 protein and active derivatives thereof
7427594	Methods and pharmaceuticals compositions for treating coronary artery disease, ischemia,and vascular disease using angiopoietins
7427602	Sustained DNA delivery from structural matrices
7427605	Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7427660	Tumor antigen
7427661	Canine IL-5 proteins and fragments thereof
7427668	Antibodies binding the TNF related protein, TNF-Y
7429379	TNF receptor action modulation
7429382	Antibodies that bind cell-associated CA 125/O772P and methods of use thereof
7429383	Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
7429385	Intracellular production of hepatitis C E1 and E2 truncated polypeptides
7429692	Sucrose synthase 3 promoter from rice and uses thereof

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.